Inventor · disambiguated record
Stephan R. Targan
Also filed as: TARGAN STEPHAN · TARGAN STEPHAN R
50 granted patents·61 pending applications·951 citations·filing 1994–2025
99Inventor score
Files withCEDARS SINAI MEDICAL CENTER79PROMETHEUS BIOSCIENCES INC8ROTTER JEROME I3TAYLOR KENT D3UNIV CALIFORNIA3
Top patents by PatentIndex Score
111 records- 0197US10322174B2Neutralizing anti-TL1A monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Jun 18, 2019·25 cites·7 claims
- 0296US11236393B2Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2018·Granted Feb 1, 2022·25 cites·20 claims
- 0396US10626180B2Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2018·Granted Apr 21, 2020·16 cites·18 claims
- 0495US11440954B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·7 cites·20 claims
- 0595US11434296B2Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A functionCEDARS SINAI MEDICAL CENTER·Filed 2020·Granted Sep 6, 2022·5 cites·16 claims
- 0695US11292848B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Apr 5, 2022·14 cites·20 claims
- 0794US11268149B2Diagnosis and treatment of inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2019·Granted Mar 8, 2022·28 cites·20 claims
- 0893US11180565B2Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2020·Granted Nov 23, 2021·3 cites·15 claims
- 0992US11999789B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·7 claims
- 1092US10633449B2Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2014·Granted Apr 28, 2020·12 cites·17 claims
- 1192US10316083B2Signature of TL1A (TNFSF15) signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2014·Granted Jun 11, 2019·15 cites·12 claims
- 1292US7838239B2Methods regarding enhanced T-cell receptor-mediated tumor necrosis factor superfamily mRNA expression in peripheral blood leukocytes in patients with crohn's diseaseHITACHI CHEMICAL CO LTD·Filed 2007·Granted Nov 23, 2010·20 cites·13 claims
- 1390US9332741B2TL1A model of inflammation fibrosis and autoimmunityCEDARS SINAI MEDICAL CENTER·Filed 2014·Granted May 10, 2016·9 cites·20 claims
- 1488US5691151AMethods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and pancaUNIV CALIFORNIA·Filed 1994·Granted Nov 25, 1997·76 cites·66 claims
- 1587US10544459B2Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2015·Granted Jan 28, 2020·4 cites·20 claims
- 1686US11312768B2Signature of TL1A (TNFSF15) signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2019·Granted Apr 26, 2022·5 cites·10 claims
- 1786US11186872B2Methods of diagnosing inflammatory bowel disease through RNASET2CEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Nov 30, 2021·8 cites·18 claims
- 1886US9305137B1Methods of identifying the genetic basis of a disease by a combinatorial genomics approach, biological pathway approach, and sequential approachTARGAN STEPHAN R·Filed 2008·Granted Apr 5, 2016·10 cites·8 claims
- 1985US2025059605A1Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 2085US2024368263A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2184US5830675AMethods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitisCEDARS SINAI MEDICAL CENTER·Filed 1995·Granted Nov 3, 1998·58 cites·24 claims
- 2283US9290543B2Compositions and methods for the therapy and diagnosis of inflammatory bowel diseaseHOSKEN NANCY ANN·Filed 2008·Granted Mar 22, 2016·6 cites·12 claims
- 2383US7993865B2Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2006·Granted Aug 9, 2011·4 cites·11 claims
- 2483US5968741AMethods of diagnosing a medically resistant clinical subtype of ulcerative colitisCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Oct 19, 1999·86 cites·46 claims
- 2583US5750355AMethods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitisCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted May 12, 1998·68 cites·44 claims
- 2682US9902996B2Methods of predicting the need for surgery in crohn's diseaseDUBINSKY MARLA C·Filed 2012·Granted Feb 27, 2018·9 cites·16 claims
- 2782US7138237B1Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigenUNIV CALIFORNIA·Filed 2000·Granted Nov 21, 2006·35 cites·16 claims
- 2880US5916748AMethod of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitisCEDARS SINAI MEDICAL CENTER·Filed 1996·Granted Jun 29, 1999·56 cites·14 claims
- 2979US7993866B2Diagnosis, prevention and treatment of crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2009·Granted Aug 9, 2011·4 cites·9 claims
- 3079US7993867B2Diagnosis, prevention and treatment of crohn's disease using the OmpC antigenCEDARS SINAI MEDICAL CENTER·Filed 2009·Granted Aug 9, 2011·4 cites·12 claims
- 3178US12269873B2Signature of TL1A (TNFSF15) signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2022·Granted Apr 8, 2025·0 cites·15 claims
- 3278US12084722B2Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2021·Granted Sep 10, 2024·0 cites·8 claims
- 3378US7662569B2Methods of assessing Crohn's disease patient phenotype by I2 serologic responseCEDARS SINAI MEDICAL CENTER·Filed 2003·Granted Feb 16, 2010·13 cites·14 claims
- 3478US6074835ADiagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1UNIV CALIFORNIA·Filed 1997·Granted Jun 13, 2000·75 cites·21 claims
- 3578US2023192835A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3678US2023381308A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 3778US2024327532A1Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3877US5874233AMethods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitisCEDARS SINAI MEDICAL CENTER·Filed 1996·Granted Feb 23, 1999·48 cites·8 claims
- 3976US12018086B2Kit comprising contiguous nucleobases, including position 76, of RS5745994CEDARS SINAI MEDICAL CENTER·Filed 2021·Granted Jun 25, 2024·0 cites·3 claims
- 4076US7790370B2Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's diseaseCEDARS SINAI MEDICAL CENTER·Filed 2003·Granted Sep 7, 2010·5 cites·15 claims
- 4176US5932429AMethods of diagnosing clinical subtypes of crohn's diseaseCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Aug 3, 1999·48 cites·32 claims
- 4276US5681699AMethods of diagnosing ulcerative colitis and Crohn's diseaseCEDARS SINAI MEDICAL CENTER·Filed 1994·Granted Oct 28, 1997·36 cites·13 claims
- 4376US2025376514A1Signature of tl1a (tnfsf15) signaling pathwayCEDARS SINAI MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 4475US9580752B2Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomyROTTER JEROME I·Filed 2009·Granted Feb 28, 2017·9 cites·6 claims
- 4575US8153443B2Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's diseaseTAYLOR KENT D·Filed 2008·Granted Apr 10, 2012·3 cites·11 claims
- 4675US2011229471A1Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2009·Application pending·0 cites
- 4770US5937862AMethods of determining the risk of pouchitis developmentCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Aug 17, 1999·37 cites·26 claims
- 4869US2021093718A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 4968US2010190162A1Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel diseaseCEDARS SINAI MEDICAL CENTER·Filed 2008·Application pending·0 cites
- 5067US2019247498A1Neutralizing anti-tl1a monoclonal antibodiesCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
Showing the top 50 of 111 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephan R. Targan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →